European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)

  • Guillaume Turc
    Neurology Department, Sainte-Anne Hospital, Paris, France 1
  • Pervinder Bhogal
    The Royal London Hospital, London, UK 5
  • Urs Fischer
    Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Switzerland 6
  • Pooja Khatri
    Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA 7
  • Kyriakos Lobotesis
    Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK 8
  • Mikaël Mazighi
    DHU NeuroVasc, Paris, France 3
  • Peter D. Schellinger
    Department of Neurology and Neurogeriatry, Johannes Wesling Medical Center Minden, University hospitals of the Ruhr-University of Bochum, Germany 12
  • Danilo Toni
    Hospital Policlinico Umberto I, Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy 13
  • Joost de Vries
    Department of Neurosurgery, Radboudumc, Nijmegen, The Netherlands 14
  • Philip White
    Institute of Neuroscience (Stroke Research Group), Newcastle, University, Newcastle Upon Tyne, UK 15
  • Jens Fiehler
    Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany 16

書誌事項

公開日
2019-03-01
権利情報
  • https://academic.oup.com/pages/standard-publication-reuse-rights
  • https://journals.sagepub.com/page/policies/text-and-data-mining-license
DOI
  • 10.1177/2396987319832140
公開者
Oxford University Press (OUP)

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Background</jats:title> <jats:p>Mechanical thrombectomy (MT) has become the cornerstone of acute ischaemic stroke management in patients with large vessel occlusion (LVO). The aim of this guideline document is to assist physicians in their clinical decisions with regard to MT.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>These Guidelines were developed based on the standard operating procedure of the European Stroke Organisation and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. An interdisciplinary working group identified 15 relevant questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence based recommendations. Expert opinion was provided if not enough evidence was available to provide recommendations based on the GRADE approach.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>We found high quality evidence to recommend MT plus best medical management (BMM, including intravenous thrombolysis whenever indicated) to improve functional outcome in patients with LVO-related acute ischaemic stroke within 6 hours after symptom onset. We found moderate quality of evidence to recommend MT plus BMM in the 6-24h time window in patients meeting the eligibility criteria of published randomized trials. These guidelines further detail aspects of prehospital management, patient selection based on clinical and imaging characteristics, and treatment modalities.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>MT is the standard of care in patients with LVO-related acute stroke. Appropriate patient selection and timely reperfusion are crucial. Further randomized trials are needed to inform clinical decision making with regard to the mothership and drip-and-ship approaches, anesthaesia modalities during MT, and to determine whether MT is beneficial in patients with low stroke severity or large infarct volume.</jats:p> </jats:sec>

収録刊行物

被引用文献 (6)*注記

もっと見る

問題の指摘

ページトップへ